Sangamo Therapeutics, Inc. (SGMOQ)
OTCMKTS · Delayed Price · Currency is USD
0.1180
+0.0080 (7.27%)
Aug 10, 2026, 3:59 PM EST
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $48.89 million as of August 10, 2026. Its market cap has decreased by -64.54% in one year.
Market Cap
48.89M
Enterprise Value
40.63M
Revenue
34.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
ChartMarket Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from 92.36M to 48.89M, a decrease of -47.07%. That is a compound annual growth rate of -2.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 48.89M | -65.41% |
| Dec 31, 2025 | 141.33M | -33.59% |
| Dec 31, 2024 | 212.82M | 120.88% |
| Dec 29, 2023 | 96.35M | -81.28% |
| Dec 30, 2022 | 514.58M | -52.90% |
| Dec 31, 2021 | 1.09B | -50.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 105.07M |
| HST Global | 99.00M |
| Biomind Labs | 62.06M |
| Cell Source | 55.94M |
| Arch Biopartners | 49.83M |
| BetterLife Pharma | 48.57M |
| Vicapsys Life Sciences | 46.94M |
| Nuo Therapeutics | 41.15M |